SRC and breast cancer: DADS may therefore suppress proliferation and invasion in human breast cancer cells by up-regulating miR-34a and consequently reducing SRC/Ras/ERK signaling, indicating that miR-34a may serve as a potential gene therapy target for enhancing the antitumor effects of DADS in breast cancer therapy.